Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Lakefront Biotherapeutics - Sponsored ADR (LKFT) had Non-Operating Income/Expense of $90.89M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$7.59M |
|
$16.96M |
|
$5.62M |
|
$1.97M |
|
$82.14M |
|
$-74.56M |
|
|
Non-Operating Income/Expense |
$90.89M |
$16.33M |
|
$16.33M |
|
$16.25M |
|
$16.25M |
|
$16.96M |
|
$16.25M |
|
$-74.56M |
|
$-74.56M |
|
65.87M |
|
65.87M |
|
$0.26 |
|
$0.26 |
|
| Balance Sheet Financials | |
$3.58B |
|
$90.06M |
|
$364.80M |
|
$3.95B |
|
$117.54M |
|
$5.68M |
|
$21.81M |
|
$139.35M |
|
$3.81B |
|
$3.81B |
|
$3.81B |
|
-- |
|
| Cash Flow Statement Financials | |
$-96.85M |
|
$71.98M |
|
$-0.60M |
|
$102.84M |
|
$78.19M |
|
$-24.65M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
30.48 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
25.95% |
|
-982.92% |
|
-982.92% |
|
-- |
|
215.34% |
|
223.61% |
|
$-95.45M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
0.27 |
|
0.12 |
|
750.36 |
|
0.43% |
|
0.43% |
|
0.41% |
|
0.43% |
|
-- |
|
$-1.45 |
|
$-1.47 |
|